S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
66,000% upside on tiny biotech? (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
66,000% upside on tiny biotech? (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
66,000% upside on tiny biotech? (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
66,000% upside on tiny biotech? (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
66,000% upside on tiny biotech? (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
66,000% upside on tiny biotech? (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
66,000% upside on tiny biotech? (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
66,000% upside on tiny biotech? (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
66,000% upside on tiny biotech? (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
66,000% upside on tiny biotech? (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
66,000% upside on tiny biotech? (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
66,000% upside on tiny biotech? (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard

Neurocrine Biosciences (NBIX) Insider Trading & Ownership

$133.37
+2.72 (+2.08%)
(As of 02/22/2024 ET)

Neurocrine Biosciences (NASDAQ:NBIX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.40%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$39.03 M
Number Of
Insiders Selling
(Last 12 Months)
12
Amount Of
Insider Selling
(Last 12 Months)
$46.27 M
Get NBIX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Neurocrine Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

NBIX Insider Buying and Selling by Quarter


Neurocrine Biosciences Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/20/2024Richard F PopsDirectorSell15,000$132.47$1,987,050.00  
2/13/2024Eiry RobertsInsiderSell1,114$132.96$148,117.44  
2/13/2024Kevin Charles GormanCEOSell2,832$133.02$376,712.64  
2/13/2024Matt AbernethyCFOSell1,352$132.85$179,613.20  
2/8/2024David W BoyerInsiderSell1,328$135.41$179,824.48  
2/8/2024Kevin Charles GormanCEOSell2,274$134.15$305,057.10  
2/8/2024Matt AbernethyCFOSell980$134.21$131,525.80  
2/6/2024David W BoyerInsiderSell456$141.96$64,733.76  
2/6/2024Kevin Charles GormanCEOSell3,040$142.18$432,227.20  
2/6/2024Matt AbernethyCFOSell1,280$142.19$182,003.20  
1/31/2024Eiry RobertsInsiderSell1,457$140.79$205,131.03  
1/31/2024Kevin Charles GormanCEOSell2,707$140.69$380,847.83  
1/31/2024Matt AbernethyCFOSell1,283$140.72$180,543.76  
1/22/2024Darin LippoldtInsiderSell10,000$139.86$1,398,600.00  
1/8/2024Kevin Charles GormanCEOSell105,835$132.44$14,016,787.40  
1/2/2024Kyle GanoInsiderSell75,000$131.47$9,860,250.00  
1/2/2024William H RastetterDirectorSell11,044$131.47$1,451,954.68  
12/22/2023Eiry RobertsInsiderSell10,000$126.74$1,267,400.00  
12/12/2023Eiry RobertsInsiderSell13,925$120.30$1,675,177.50  
12/8/2023Eiry RobertsInsiderSell300$120.10$36,030.00  
12/6/2023Darin LippoldtInsiderSell20,830$119.86$2,496,683.80  
12/1/2023Gary A LyonsDirectorSell5,000$116.77$583,850.00  
11/29/2023Jude OnyiaInsiderSell2,331$113.57$264,731.67  
11/27/2023Darin LippoldtInsiderSell10,919$112.27$1,225,876.13  
10/2/2023David W BoyerInsiderSell1,437$112.68$161,921.16  
9/12/2023Gary A LyonsDirectorSell5,000$115.02$575,100.00  
9/1/2023Gary A LyonsDirectorSell5,000$110.06$550,300.00  
9/1/2023Julie CookeInsiderSell824$110.93$91,406.32  
8/30/2023David W BoyerInsiderSell2,733$107.60$294,070.80  
8/28/2023Ingrid DelaetInsiderSell1,431$107.52$153,861.12  
8/21/2023Jude OnyiaInsiderSell3,198$107.37$343,369.26  
8/21/2023Kevin Charles GormanCEOSell9,328$107.40$1,001,827.20  
8/21/2023Matt AbernethyCFOSell2,132$107.39$228,955.48  
5/1/2023Julie CookeInsiderSell11,397$103.89$1,184,034.33  
5/1/2023William H RastetterDirectorSell4,300$101.43$436,149.00  
4/24/2023Eiry RobertsInsiderSell14,400$103.48$1,490,112.00  
4/21/2023William H RastetterDirectorSell6,034$105.04$633,811.36  
4/19/2023William H RastetterDirectorSell903$105.00$94,815.00  
2/23/2023Neurocrine Biosciences IncMajor ShareholderBuy4,395,588$8.88$39,032,821.44  
(Data available from 1/1/2013 forward)












NBIX Insider Trading Activity - Frequently Asked Questions

What percentage of Neurocrine Biosciences stock is owned by insiders?

4.40% of Neurocrine Biosciences stock is owned by insiders. Learn more on NBIX's insider holdings.

Which Neurocrine Biosciences insiders have been buying company stock?

The following insider purchased NBIX shares in the last 24 months: Neurocrine Biosciences Inc ($39,032,821.44).

How much insider buying is happening at Neurocrine Biosciences?

Insiders have purchased a total of 4,395,588 NBIX shares in the last 24 months for a total of $39,032,821.44 bought.

Which Neurocrine Biosciences insiders have been selling company stock?

The following insiders have sold NBIX shares in the last 24 months: Darin Lippoldt ($8,285,389.96), David W Boyer ($853,720.03), Eiry Roberts ($4,982,223.40), Eric Benevich ($10,226,687.89), Gary A Lyons ($5,374,750.00), Ingrid Delaet ($153,861.12), Jude Onyia ($608,100.93), Julie Cooke ($1,350,840.65), Kevin Charles Gorman ($17,369,891.33), Kyle Gano ($9,860,250.00), Malcolm Lloyd-Smith ($2,281,421.35), Matt Abernethy ($3,739,732.98), Richard F Pops ($3,131,550.00), Stephen A Sherwin ($3,565,800.00), and William H Rastetter ($3,635,139.08).

How much insider selling is happening at Neurocrine Biosciences?

Insiders have sold a total of 630,454 Neurocrine Biosciences shares in the last 24 months for a total of $75,419,358.72 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:NBIX) was last updated on 2/23/2024 by MarketBeat.com Staff